LXK INAMI Holding ApS: Financial statements 2023
CVR: 40132635
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
LXK INAMI Holding ApS (CVR 40132635) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -10,537 and a net result of DKK -13,888 compared with DKK -68,590 the year before. Equity in the 2023 report amounted to DKK -308,915.
- Gross Profit
- DKK -10,537
- Profit/Loss
- DKK -13,888
- Equity
- DKK -308,915
- Total Assets
- DKK 13,868
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -11K | -14K | -309K | - |
| 2022 | - | -6K | -69K | -295K | 0 |
| 2021 | - | -13K | -261K | -226K | 0 |
| 2020 | - | -6K | -5K | 35K | 0 |
| 2019 | - | - | 0 | 1 | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
LXK INAMI Holding ApS has published its annual report for 2022. Gross profit came to DKK -6,188, and the net result was DKK -68,590.
About LXK INAMI Holding ApS
LXK INAMI Holding ApS is a Danish company of the type Anpartsselskab based in Randers C, founded in 2019. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named LXK INAMI Holding IVS and UK Vexo LXK Medical Group IVS. The management consists of Michael Dalgaard Zile. The company is owned by Michael Dalgaard Zile and UAB "Medicinos Turizmo Paslaugos". According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -18,300 and a net result of DKK -20,986 compared with DKK -6,205 the year before. Equity in the 2025 report amounted to DKK -336,107.
